Converge Biotech Private Limited

Converge Biotech Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24233TG2014PTC095410 Incorporated 26 August 2014 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2024
₹60.73 Cr
▼ 6% YoY
Net profit · FY 2024
₹2.53 Cr
Net margin 4.2%
EBITDA · FY 2024
₹4.63 Cr
EBITDA margin 7.6%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹8.83 Cr
Satisfied ₹2.55 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
183
Provident fund records

About Converge Biotech Private Limited

Data last updated:

Converge Biotech Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 August 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2014PTC095410. Its GSTIN is 36AAFCC7743Q1ZZ (Telangana). The company holds 9 GST registrations, all of them active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Bijjala Arun Kumar (Managing Director) and Bukka Srinivasu.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2024, the company reported a revenue of ₹60.73 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹2.53 Cr (net margin 4.2%) and EBITDA of ₹4.63 Cr (EBITDA margin 7.6%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 33% over five years.

The company has about 183 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Converge Biotech. As per MCA filings, the company has open charges of ₹8.83 Cr and satisfied charges of ₹2.55 Cr on record. Court records list 18 cases involving the company, including 17 filed by the company and 1 filed against it; 10 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹48.9 Lakh; the latest was in October 2019.

Converge Biotech Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0040052). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website convergebio.in.

Company details

CIN U24233TG2014PTC095410
Registration Number 095410
Incorporation Date 26 August 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0040052
Key People
Bijjala Arun Kumar Managing Director Bukka Srinivasu Director Chandra Shekar Bukka Director

Recognitions & Rankings of Converge Biotech

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-TS-02-0040052

Contact details

Converge Biotech Private Limited's registered office is in Hyderabad, Telangana. Its website is convergebio.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    convergebio.in
  • Social Media
  • Registered Address
    7 – 2 – 1735 & 7 – 2 – 1813/5, 2nd And 3rd Floor Plot No.3 Street 1 Czech Colony, Hyderabad, Telangana, India – 500018
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Converge Biotech Private Limited, buy the company report.

Comprehensive company report
Converge Biotech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Converge Biotech operates one associated brand: Converge Biotech. Each brand links to its own profile.

BrandDescriptionWebsite
Converge Biotech
Branded pharmaceutical formulations for chronic care are manufactured and distributed.convergebio.in

Business activity

The main business activity of Converge Biotech is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of Converge Biotech Private Limited, buy the company report.

Financials of Converge Biotech Private Limited

FY 2025 filings available

Converge Biotech Private Limited reported revenue of ₹60.73 Cr (down 6% YoY) for FY 2024.

Revenue · FY 2024
₹60.73 Cr ▼ 6%
Net profit · FY 2024
₹2.53 Cr margin 4.2%
EBITDA · FY 2024
₹4.63 Cr margin 7.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 21%
5 years · compounded
▲ 33%
EBITDA CAGR growth
1 year
▲ 637%
3 years · compounded
▲ 48%
5 years · compounded
▲ 41%

Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 33%. EBITDA rose 637% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations₹60.73 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.63 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.53 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin7.6%
Net Profit Margin4.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Converge Biotech Private Limited, buy the company report.

Board of directors of Converge Biotech Private Limited

Converge Biotech has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bukka Srinivasu
Also directs: Vaishnavi Builders LLP, Santhoshimatha Bio Fuels Private Limited, Santhoshimathaa Edible Oils Refinery Private Limited and 1 more
Director26 Aug 201412 Years 2 MonthsCurrent
Chandra Shekar Bukka
Also directs: Vaishnavi Builders LLP, Santhoshimatha Bio Fuels Private Limited, Santhoshimathaa Edible Oils Refinery Private Limited and 1 more
Director26 Aug 201412 Years 2 MonthsCurrent
Bijjala Arun Kumar
Also directs: Converge Specialty Private Limited
Managing Director26 Aug 201412 Years 2 MonthsCurrent
Bijjala KavithaDirector26 Aug 201412 Years 2 MonthsCurrent
View all directors

Auditor

Converge Biotech Private Limited is audited by N N RAO & CO for the financial year 2024.

Auditor firmFinancial yearFirm registration number
N N RAO & COFY 2024008283S

Shareholding

The shareholding of Converge Biotech Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Converge Biotech Private Limited, buy the company report.

Charges & borrowings

Open charges
₹8.83 Cr
Satisfied charges
₹2.55 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹8.83 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Sep 2025101177170Hdfc Bank Limited₹25 LakhOpen
29 Feb 2024100925785Hdfc Bank Limited₹24.06 LakhOpen
27 Oct 2021100499017Hdfc Bank Limited₹8.34 CrOpen
06 Jul 2020100350280Karnataka Bank Ltd.₹35 LakhSatisfied
27 Apr 2020100335076Karnataka Bank Ltd.₹20 LakhSatisfied

To see the full charge records of Converge Biotech Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Converge Biotech Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹48.9 Lakh; the latest was in October 2019.

Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹48.9 Lakh

Deals on record (2 of 2)

WhenDealAmountParties
Oct 2019Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 4 individuals
Mar 2019Funding round₹48.9 LakhInvestors: 4 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Converge Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Converge Biotech Private Limited has a workforce of 183 employees on its EPFO records as of Mar 29, 2025, across 1 active EPFO establishment.

Employee count
183
Active EPFO establishments
1
Employee growth
6.4%

GST

Converge Biotech has 9 GST registrations: 9 active. The first 4 active GSTINs are listed below.

Total GSTINs
9
Active
9
GSTINStateStatusRegistered on
36AAFCC7743Q1ZZTelanganaActive01 Jul 2017
27AAFCC7743Q1ZYMaharashtraActive06 Feb 2018
09AAFCC7743Q1ZWUttar PradeshActive10 Jul 2020
29AAFCC7743Q1ZUKarnatakaActive21 Jul 2021

To see the full GST registrations and return filing status of Converge Biotech Private Limited, buy the company report.

Recent activity

Converge Biotech Private Limited has 9 board changes on record since 2014: 4 appointments and 5 cessations. The latest: Bijjala Arun Kumar ceased to be Director on 29 Feb 2024.

AGM
Converge Biotech Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.00 Lakh with Charge ID 101177170 was registered on 20 Sep 2025.
Filing
Converge Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited of Rs. 834.03 Lakh registered on 27 Oct 2021 with Charge ID 100499017 was modified on 17 May 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 24.06 Lakh with Charge ID 100925785 was registered on 29 Feb 2024.
Ceased
Bijjala Arun Kumar ceased to be Director.
Charges
A charge registered on 06 Jul 2020 via Charge ID 100350280 with Karnataka Bank Ltd. was fully satisfied on 15 Nov 2021.
Charges
A charge registered on 27 Apr 2020 via Charge ID 100335076 with Karnataka Bank Ltd. was fully satisfied on 15 Nov 2021.
Charges
A charge registered on 29 Dec 2016 via Charge ID 100072138 with Karnataka Bank Ltd. was fully satisfied on 15 Nov 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 834.03 Lakh with Charge ID 100499017 was registered on 27 Oct 2021.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 35.00 Lakh with Charge ID 100350280 was registered on 06 Jul 2020.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 20.00 Lakh with Charge ID 100335076 was registered on 27 Apr 2020.

11 earlier events are in the company report.

News

Frequently asked questions

Converge Biotech is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 August 2014 (12+ years old) and is registered under CIN U24233TG2014PTC095410.

Converge Biotech has 4 current directors:

The latest financial statements of Converge Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Converge Biotech is 36AAFCC7743Q1ZZ, registered in Telangana. The company has 9 GST registrations in all, of which 9 are active. Other active GSTINs include 27AAFCC7743Q1ZY (Maharashtra), 09AAFCC7743Q1ZW (Uttar Pradesh), 29AAFCC7743Q1ZU (Karnataka).

The CIN (Corporate Identification Number) of Converge Biotech is U24233TG2014PTC095410. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Converge Biotech has 18 court cases on record: 17 filed by the company and 1 filed against it. 10 are pending. Most are in the district courts.

Converge Biotech was incorporated on 26 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.

Converge Biotech has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹48.9 Lakh; the latest was in October 2019.

Bijjala Arun Kumar ceased to be Director on 29 Feb 2024. Indira Bukka ceased to be Director on 03 Sep 2016. Janamma Bukka ceased to be Director on 03 Sep 2016. Converge Biotech has 9 board changes on record in total.

Yes, Converge Biotech is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0040052).